Skip to main content

Errata - English

PDF CSV September 18, 2022 through September 18, 2024 See all Errata for USP–NF How to use
Enter the title of the monograph
Monograph Title Section Source Publication Page Number Errata Official Date Target Errata Print Publication Target Online Fix Publication Description
DOXORUBICIN HYDROCHLORIDE FOR INJECTION IMPURITIES/Organic Impurities USPNF Online Online 1-Nov-2022 NA NA In Analysis: Change
P = potency of doxorubicin in USP Doxorubicin Hydrochloride RS (µg/mg)
to:
P = potency of doxorubicin hydrochloride in USP Doxorubicin Hydrochloride RS (µg/mg)
ENZACAMENE ASSAY/Procedure USPNF Online Online 1-Dec-2022 NA NA In Analysis: Change
CU = concentration of enzacamene in the Sample solution (mg/mL)
to:
CU = concentration of Enzacamene in the Sample solution (mg/mL)
NALOXONE HYDROCHLORIDE IMPURITIES USPNF Online Online 1-Dec-2022 NA NA In Limit of Naloxone Related Compound D: Delete
Sensitivity solution: 1.25 µg/mL of USP Naloxone Related Compound D RS in 0.1 N hydrochloric acid
AND
In System suitability/Samples: Delete
Sensitivity solution,… Read More
CALCIUM L-5-METHYLTETRAHYDROFOLATE IMPURITIES/Related Compounds USPNF Online Online 1-Nov-2022 NA NA In Analysis: Change
CS = concentration of USP Calcium DL-5-Methyltetrahydrofolate RS in the Standard solution (mg/mL)
to:
CS = concentration of USP Calcium D,L-5-Methyltetrahydrofolate RS in the Read More
SITAGLIPTIN PHOSPHATE CHEMICAL INFORMATION USPNF Online Online 1-Nov-2022 NA NA Change
523.32
to:
523.33
AND
Change
(3R)-3-Amino-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl-4-(2,4,5-trifluorophenyl)butan-1-one phosphate monohydrate
to:
(3R)-3-Amino-1-[3-(trifluoromethyl)-… Read More
DOFETILIDE CHEMICAL INFORMATION USPNF Online Online 1-Nov-2022 NA NA Change
β-[(p-Methanesulfonamidophenethyl)methylamino]methane sulfono-p-phenetidide
to:
N-{4-[2-(Methyl{2-[4-(methylsulfonamido)phenoxy]ethyl}amino)ethyl]phenyl}methanesulfonamide
CALCIUM UNDECYLENATE ASSAY/Procedure USPNF Online Online 1-Nov-2022 NA NA In Solution A: Change
0.15 N hydrochloric acid in water prepared as follows. Transfer 150 mL of hydrochloric acid to a 500-mL volumetric flask, dilute with water to volume, and mix well.
to:
0.15 N hydrochloric acid in water prepared as follows.… Read More
CALCIUM L-5-METHYLTETRAHYDROFOLATE IDENTIFICATION USPNF Online Online 1-Nov-2022 NA NA In A. Spectroscopic Identification Tests <197>, Infrared Spectroscopy: 197K: Change
USP Calcium DL-5-Methyltetrahydrofolate RS
to:
USP Calcium D,L-5-Methyltetrahydrofolate RS
TETRACYCLINE HYDROCHLORIDE SPECIFIC TESTS/Bacterial Endotoxins Test <85> USPNF Online Online 1-Nov-2022 NA NA Change
Where the label states tetracycline hydrochloride must be subjected to further processing during the preparation of injectable dosage forms, the level of bacterial endotoxins are such that the requirement under the relevant dosage form monograph(s) in… Read More
DOXORUBICIN HYDROCHLORIDE INJECTION ASSAY/Procedure USPNF Online Online 1-Nov-2022 NA NA In Analysis: Change
P = potency of doxorubicin in USP Doxorubicin Hydrochloride RS (µg/mg)
to:
P = potency of doxorubicin hydrochloride in USP Doxorubicin Hydrochloride RS (µg/mg)
DIAZOXIDE IMPURITIES/Organic Impurities USPNF Online Online 1-Nov-2022 NA NA In footnote a in Table 2: Change
7-Chloro-2H-benzothiadiazin-3(4H)-one 1,1-dioxide.
to:
7-Chloro-2H-1,2,4-benzothiadiazin-3(4H)-one 1,1-dioxide.
CALCIUM L-5-METHYLTETRAHYDROFOLATE IMPURITIES/Enantiomeric Purity USPNF Online Online 1-Nov-2022 NA NA In Standard solution: Change
USP Calcium DL-5-Methyltetrahydrofolate RS
to:
USP Calcium D,L-5-Methyltetrahydrofolate RS
DOXORUBICIN HYDROCHLORIDE FOR INJECTION ASSAY/Procedure USPNF Online Online 1-Nov-2022 NA NA In Analysis: Change
P = potency of doxorubicin in USP Doxorubicin Hydrochloride RS (µg/mg)
to:
P = potency of doxorubicin hydrochloride in USP Doxorubicin Hydrochloride RS (µg/mg)
PRIMIDONE TABLETS ASSAY/Procedure USPNF Online Online 1-Dec-2022 NA NA In Sample solution: Change
0.05 mg/mL of primidone from the Standard stock solution in Diluent
to:
0.05 mg/mL of primidone from the Sample stock solution in Diluent
ANETHOLE DEFINITION USPNF Online Online 1-Nov-2022 NA NA Change
(E)-1-methyl-4-(1-propenyl) benzene
to:
(E)-1-methoxy-4-(1-propenyl) benzene
CALCIUM L-5-METHYLTETRAHYDROFOLATE ASSAY/Procedure USPNF Online Online 1-Nov-2022 NA NA In System suitability solution: Change
USP Calcium DL-5-Methyltetrahydrofolate RS
to:
USP Calcium D,L-5-Methyltetrahydrofolate RS
AND
In Standard solution: Change
USP Calcium DL-5-Methyltetrahydrofolate RS
to:
USP Calcium D,L-5-… Read More
TETRACYCLINE HYDROCHLORIDE ADDITIONAL REQUIREMENTS/Labeling USPNF Online Online 1-Nov-2022 NA NA Change
Where tetracycline hydrochloride must be sterile or subjected to further processing during the preparation of injectable dosage forms to ensure acceptable levels of bacterial endotoxins, it is so labeled.
to:
Where Tetracycline Hydrochloride must be… Read More
DOXORUBICIN HYDROCHLORIDE INJECTION IMPURITIES/Organic Impurities USPNF 2022 Online Online 1-Nov-2022 NA NA In Analysis: Change
P = potency of doxorubicin in USP Doxorubicin Hydrochloride RS (µg/mg)
to:
P = potency of doxorubicin hydrochloride in USP Doxorubicin Hydrochloride RS (µg/mg)
DOXAZOSIN MESYLATE IMPURITIES/Organic Impurities USPNF Online Online 1-Nov-2022 NA NA In Analysis: Change
CS = concentration of the corresponding USP Doxazosin Related Compound RS or USP Doxazosin Mesylate RS (for calculating unspecified impurities) in the Standard solution (mg/mL)
to:
CS… Read More
CEFTIOFUR HYDROCHLORIDE ASSAY/Procedure USPNF Online Online 1-Oct-2022 NA NA In Analysis: Change
Calculate the percentage of ceftiofur (C19H17N5O7S3) in the portion of Ceftiofur Hydrochloride taken:
Result = (rU/rS Read More
N-Benzoyl-L-arginine Ethyl Ester Hydrochloride REAGENT SPECIFICATIONS USPNF Online Online 1-Dec-2022 NA NA Change
Crystallized Trypsin (USP Monograph).
to:
Trypsin (USP Monograph).
SODIUM PICOSULFATE IMPURITIES/Organic Impurities USPNF Online Online 1-Oct-2022 NA NA In Buffer: Change
cetylrimethylammonium bromide,
to:
cetyltrimethylammonium bromide,
LANSOPRAZOLE DELAYED-RELEASE CAPSULES IMPURITIES/Organic Impurities USPNF Online Online 1-Oct-2022 NA NA Delete
Blank: Methanol and Diluent (1:9)
TERAZOSIN CAPSULES ASSAY/Procedure USPNF Online Online 1-Oct-2022 NA NA In Hydrochloric acid solution: Change
0.1 N methanolic hydrochloric acid
to:
0.01 N methanolic hydrochloric acid
<621> CHROMATOGRAPHY ADJUSTMENT OF CHROMATOGRAPHIC CONDITIONS USPNF Online Online 1-Dec-2022 NA NA In Liquid Chromatography: Isocratic Elution/Injection volume: Change
L2 = internal diameter of the column used (mm)
dc1 = particle size indicated in the monograph (µm)
dc2 =… Read More
0.1 M ZINC SULFATE VS STANDARDIZATION USPNF Online Online 1-Dec-2022 NA NA In Standardization with visual end point: Change
M = mL edetate disodium × edetate disodium/mL ZnSO4
to:
M = mL edetate disodium × M edetate disodium/mL ZnSO4
AND
In Standardization with potentiometric end point… Read More
LATANOPROST ASSAY/Procedure USPNF Online Online 1-Dec-2022 NA NA Change
Standard solution: Transfer 2.0 mg/mL of USP Latanoprost RS into a suitable volumetric flask, dissolve in dehydrated alcohol equivalent to 20% of the final volume, and dilute with chromatographic hexane to volume.
Sample solution:… Read More
ACYCLOVIR ASSAY/Procedure USPNF Online Online 1-May-2023 NA NA In the Sample solution: Change
0.1 N sodium hydroxide
to:
0.01 N sodium hydroxide
<621> CHROMATOGRAPHY ADJUSTMENT OF CHROMATOGRAPHIC CONDITIONS USPNF Online Online 1-Dec-2022 NA NA In Liquid Chromatography: Isocratic Elution/Injection volume: Change
Result = (Vinj2 = Vinj1 (L2 dc22 )/(L1… Read More
<621> CHROMATOGRAPHY SYSTEM SUITABILITY USPNF Online Online 1-Dec-2022 NA NA Change
System Repeatability—Assay of an Active Substance or an Excipient
to:
System Repeatability
MAGNESIUM OXIDE IMPURITIES/Limit of Calcium USPNF Online Online 1-Dec-2022 NA NA In Analysis: Change
CU = concentration of Magnesium Hydroxide in the Sample solution (mg/mL)
to:
CU = concentration of Magnesium Oxide in the Sample solution (mg/mL)
<659> PACKAGING AND STORAGE REQUIREMENTS GENERAL DEFINITIONS/Packaging Definitions Second Supplement to USP43–NF38 Online 1-Dec-2025 NA NA In Light-resistant container: Change
〈661.2〉, Functionality, Spectral Transmission Requirements for Light-Resistant Components and Systems.
to:
〈661.2〉, Functionality Test Method, Spectral Transmission Requirements for Light-… Read More